2019
DOI: 10.1016/j.bioorg.2019.01.063
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 28 publications
(9 citation statements)
references
References 24 publications
0
8
1
Order By: Relevance
“…ROS accumulations were also frequently observed after the treatment of CBSIs. [ 26 ] Therefore, we evaluated ROS production in HCC cells using the fluorescent probe DCFH‐DA by flow cytometry and fluorescence microscopy. The intracellular ROS accumulations were markedly increased after W463 treatment in HCC cells (Figure 5A).…”
Section: Resultsmentioning
confidence: 99%
“…ROS accumulations were also frequently observed after the treatment of CBSIs. [ 26 ] Therefore, we evaluated ROS production in HCC cells using the fluorescent probe DCFH‐DA by flow cytometry and fluorescence microscopy. The intracellular ROS accumulations were markedly increased after W463 treatment in HCC cells (Figure 5A).…”
Section: Resultsmentioning
confidence: 99%
“…We also investigated the effects of compounds in inducing A549 cells apoptosis using fluorescence microscope by staining with DAPI [ 34 , 35 ]. The results in Figure 7 A indicate that the nuclear structure of the control cells was intact with round shape while the A549 cells treated with the 4d and 4n showed nuclear concentration and micronuclei formation.…”
Section: Resultsmentioning
confidence: 99%
“…According to literature, monohalogenated derivatives are broadly applied in biological studies and present better results due to lower persistence and better absorption and distribution in vivo. [8][9][10]23] In view of the results outlined above, three promising derivatives (4, 5 and 17) were selected, on the basis of their high activity levels, to perform a cell viability study at various concentrations (from 0.1 to 100 μM) in tumoral (HeLa) and nontumoral (HEK-293, human embryonic kidney) cell lines for 24 h to study their selectivity. The data were compared to those of the clinically used anticancer drug etoposide (Figure 5).…”
Section: Bioactivity Studiesmentioning
confidence: 99%